Further, the impact of HCMV infection on COX-2, 5-LO, and PRLR expression suggests the use of inhibitors and modulators of these enzymes as potential attractive therapeutic options in the treatment of various cancers [15]. Here, PTGS2 is linked to cytomegalovirus infection.